Skip to Content

Triacelluvax

Active Substance: diphtheria toxoid, haemagglutinin filamentous, adsorbed, pertactin, pertussis toxin, tetanus toxoid
Common Name: combined diphtheria, tetanus and acellular pertussis vaccine
ATC Code: J07AJ
Marketing Authorisation Holder: Chiron S.p.A.
Active Substance: diphtheria toxoid, haemagglutinin filamentous, adsorbed, pertactin, pertussis toxin, tetanus toxoid
Status: Withdrawn
Authorisation Date: 1999-01-11
Therapeutic Area: Diphtheria Whooping Cough Immunization Tetanus
Pharmacotherapeutic Group: Vaccines

Therapeutic Indication

TRIACELLUVAX is indicated for active immunisation of children from 6 weeks up to 7 years of age against diphtheria, tetanus and pertussis.

The marketing authorisation for Triacelluvax has been withdrawn at the request of the marketing authorisation holder.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide